Comprehensive Exam Preparation for NRNP 6675 Midterm, Exams of Nursing

Download Comprehensive Exam Preparation for NRNP 6675 Midterm and more Exams Nursing in PDF only on Docsity!

CURRENTLY TESTING SOLUTIONS OF NRNP 6675 MIDTERM

EXAM LATEST 2024/NRNP6675 WEEK 6 MIDTERM WITH

ACTUAL CORRECT DETAILED ANSWERS

Substance intoxication - ANSWER-Syndrome from recent ingestion or exposure to a substance Tardive dyskinesia - ANSWER-Abnormal involuntary movements affecting face, mouth, tongue Delusional disorder - ANSWER-Deeply held belief lasting at least one month without prominent hallucinations Preoccupation with castration - ANSWER-Serious if carried out without medical supervision, consistent with specific disorders CPT - ANSWER-System for describing medical and surgical procedures Milky urine on Chlorpromazine - ANSWER-May be a harmless response to the medication Turner's syndrome - ANSWER-Condition from absence of second female sex chromosome (XO) Negative symptom of schizophrenia - ANSWER-Isolation and impaired self-care Distinguishing OCD from psychosis - ANSWER-Patients with OCD acknowledge symptoms' unreasonable nature Psychosis - ANSWER-Condition with delusions, disorganized thoughts, and poor self-care

Obsessive Thoughts - ANSWER-Common in patients with psychosis OCD - ANSWER-Characterized by less bizarre obsessions DSM- 5 - ANSWER-System for describing medical procedures and services Medicare - ANSWER-Federal program for individuals 65+ and disabled HIPPA - ANSWER-Regulation for patient data privacy Nurse Practitioner Scope - ANSWER-Legal description important to avoid practicing without a license Psychoactive Substance - ANSWER-Most widely consumed: caffeine Tardive Dyskinesia Treatment - ANSWER-Cogentin (benztropine) or Artane (trihexyphenidyl) APRN Consensus Model - ANSWER-Merged foci to allow NPs to work across specialties Alcohol Blood Level 0.05% - ANSWER-Impairs thought judgment and motor actions Dopamine Hypothesis of Schizophrenia - ANSWER-Theory linking schizophrenia to dopaminergic activity Social phobia - ANSWER-Fear of social situations Specific phobia - ANSWER-Fear of specific objects or situations General anxiety disorder unspecified - ANSWER-Non-specific anxiety disorder

Obsessive-compulsive disorder - ANSWER-Disorder characterized by obsessions and compulsions Residential treatment - ANSWER-Inpatient treatment in a residential facility Partial hospitalizations - ANSWER-Structured treatment program without full hospitalization Outpatient treatment - ANSWER-Treatment received without being admitted to a hospital Telephilia - ANSWER-Obscene phone calling for sexual arousal Fear - ANSWER-Specific, immediate response to a threat Stress - ANSWER-Mental or emotional strain First trimester - ANSWER-Least hazardous time for methadone withdrawal during pregnancy Neuroadaptation - ANSWER-Neurochemical changes from repeated drug use Sexual sadism - ANSWER-Intense arousal from another's suffering Sudden onset of OCD - ANSWER-More than half have a sudden onset Exhibitionism - ANSWER-Recurrent urge to expose genitals to strangers Hospitalization for substance use disorder - ANSWER-Required for severe withdrawal risk or overdose Full practice - ANSWER-Nursing practice model recommended for NPs Medicare coverage - ANSWER-Includes individuals 65+, disabled, and those in poverty

Libido neurotransmitter - ANSWER-Dopamine increases libido. Poor prognosis factors in OCD - ANSWER-Childhood onset and co-existing major depressive disorder indicate poor prognosis. Schizophrenia misconception - ANSWER-Diagnosis isn't solely history-based; dopamine level isn't a diagnostic test. Trichotillomania - ANSWER-Chronic disorder involving hair pulling leading to hair loss. Neuroleptic malignant syndrome risks - ANSWER-Rapid dose escalation and higher potency antipsychotics increase risk. Mesocortical pathway D2 blockade effect - ANSWER-Reduces negative symptoms but increases EPS. PCP and Ketamine effects - ANSWER-Block NMDA receptors to exert unique behavioral effects. Substance intoxication diagnosis - ANSWER-Describes signs and symptoms post recent substance exposure. Contingency management therapy - ANSWER-Reinforces behaviors through a psychology principle. Social determinants of health - ANSWER-Conditions influencing people's lives, work, and health. ANCC recertification rules - ANSWER-Need 25 credit hours yearly, 1000 clinical practice hours in 5 years, and 25 pharmacotherapy hours. School violence risk factors - ANSWER-Include bullying, being bullied, isolation, and involvement in school organizations.

Dependent personality disorder - ANSWER-Subordinates own needs, lacks self-confidence, discomfort when alone Avoidant personality disorder - ANSWER-Avoids major areas of life, lacks self-confidence, discomfort when alone Antisocial personality disorder - ANSWER-Displays antisocial behavior, violates rights of others Lithium toxicity symptoms - ANSWER-Generalized convulsions, oliguria, renal failure Munchausen syndrome by proxy - ANSWER-Fabricates/inflicts injury on a child for medical attention Self-care strategies for certification exam - ANSWER-Study environment, sleep, study duration, avoid caffeine/sugar Paranoid personality disorder - ANSWER-Suspicious, preoccupied with trustworthiness, angry, secretive Alcohol-related psychiatric emergency - ANSWER-Oculomotor disturbances, ataxia, confusion - Wernicke's encephalopathy Cluster A personality disorders - ANSWER-Schizotypal, schizoid, paranoid traits Financial abuse/exploitation - ANSWER-Misuse of funds for personal gain Emotional/psychological abuse - ANSWER-Non-physical mistreatment causing emotional harm Trauma bonding - ANSWER-Strong emotional connection with an abuser Cluster A personality traits - ANSWER-Includes schizotypal, schizoid, and paranoid subtypes

Cultural Dimensions Therapy - ANSWER-Framework by Hofstede on culture's impact on values Paranoid personality disorder treatment - ANSWER-Involves group therapy, behavioral therapy, or psychotherapy Health disparities - ANSWER-Differences in healthcare quality among individuals or groups Older Caucasian men - ANSWER-Population with the highest suicide incidence Straight salary - ANSWER-Fixed pay according to a set job description Obsessive-compulsive personality disorder - ANSWER-Characterized by emotional constriction and orderliness Lifetime prevalence of anxiety - ANSWER-Women have a higher lifetime prevalence than men Lifetime Prevalence of Anxiety - ANSWER-Not gender specific NP Practice Parameters for Buprenorphine - ANSWER-NPs with full practice authority can prescribe buprenorphine under state license Buprenorphine Patient Limit - ANSWER-NPs can provide buprenorphine to 300 patients per month Buprenorphine Training Requirement - ANSWER-NPs must complete specific training to prescribe buprenorphine Prevalence of Drinking Alcohol - ANSWER-Higher education and income correlate with less alcohol consumption Generalized Anxiety Disorder Diagnosis - ANSWER-Fear, worry, and restlessness linked to hypoglycemia

Benzodiazepine Withdrawal - ANSWER-Withdrawal can develop for weeks; immediate cessation not recommended Legal Practice of PMHNP - ANSWER-Prescriptive privileges vary; not all are primary providers PTSD Flashbacks - ANSWER-Recurring trauma experiences; clinical feature of PTSD NP vs. PA Differences - ANSWER-NPs have independent practice; PAs work under physician supervision PMHNP Credentials - ANSWER-PMHNP-BC is a common designation for psychiatric-mental health NPs Gender Role Behavior Variations - ANSWER-Non-conformity in gender role behavior Major Neurotransmitters in Anxiety - ANSWER-Associated with anxiety; include those responsive to drug treatment Glutamate - ANSWER-An excitatory neurotransmitter in the brain Norepinephrine - ANSWER-A neurotransmitter involved in stress response and mood regulation Serotonin - ANSWER-A neurotransmitter that regulates mood, appetite, and sleep GABA - ANSWER-An inhibitory neurotransmitter that reduces neuronal excitability Dopamine - ANSWER-A neurotransmitter associated with pleasure and reward Schizophrenia Lifetime Prevalence - ANSWER-Approximately 50% according to US epidemiology

Schizophrenia Onset Peak in Men - ANSWER-Occurs between 10 to 25 years of age Abuse Indicators - ANSWER-Delay in seeking treatment, inconsistent explanations, psychological distress Telepsychiatry Effectiveness - ANSWER-Comparable to in-person care in various aspects Psychosexual Definition - ANSWER-Describes personality development and functioning Bleuler's 4 As - ANSWER-Associations, affect, autism, ambivalence Agoraphobia - ANSWER-Fear or anxiety about difficult escape places Gender Discordance - ANSWER-Discrepancy between anatomical sex and gender identity Cannabis Effects - ANSWER-Excludes mild bradycardia as a common effect Compulsion - ANSWER-Recurrent behavior interfering with normal routine Firm Gender Conviction Age - ANSWER- 2 - 3 years of age for most individuals Akinesia Symptoms - ANSWER-Absent movement, difficulty starting activities, flat affect, avolition Catatonic Schizophrenia Type - ANSWER-Marked disturbance in motor function with stupor, rigidity, or excitement Akathisia Symptoms - ANSWER-Inability to remain still, motor restlessness Contingency Management - ANSWER-Therapy reinforcing behaviors through psychological principles